Association of 5-HTR2A and 5-HTR2C serotonin receptor gene polymorphisms with depression risk in patients with coronary heart disease

Bulletin of Experimental Biology and Medicine

Volumn 156, Issue 5, 2014, Pages 680-683

  Golimbet, V E ^a   Volel', B A ^a   Dolzhikov, A V ^a   Korovaitseva, G I ^a   Isaeva, M I ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

coronary heart disease; depression; gene; personal anxiety; serotonin receptors

Indexed keywords

5 HTR2A SEROTONIN RECEPTOR; 5 HTR2C SEROTONIN RECEPTOR; CYSTEINE; SERINE; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ADULT; AGED; ALLELE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; HAMILTON SCALE; HEART DISEASE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; VERY ELDERLY; ADOLESCENT; AMINO ACID SUBSTITUTION; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PSYCHOLOGY; RISK; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CORONARY DISEASE; DEPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RISK; YOUNG ADULT;

EID: 84898809628     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-014-2424-1     Document Type: Article

References (9)

1. V. I. Barskii, M. G. Aksenova, O. B. Kozlova, et al., Gig. San., No. 6, 47-50 (2010).
2. T. G. Noskova, A. V. Kazantseva, A. E. Gareeva, et al., Genetika, 45, No. 6, 842-848 (2009).
3. M. J. Choi, H. J. Lee, H. J. Lee, et al., Neuropsychobiology, 49, No. 1, 38-41 (2004).
4. B. Lerer, F. Macciardi, R. H. Segman, et al., Mol. Psychiatry, 6. No. 5, 579-585 (2001).
5. M. Masellis, V. Basile, H. Y. Meltzer, et al., Neuropsychopharmacology, 19, No. 2, 123-132 (1998).
6. D. Nakatani, H. Sato, Y. Sakata, et al., Am. Heart J., 150, No. 4, 652-658 (2005).
7. C. Otte, J. McCaffery, S. Ali, and M. A. Whooley, Am. J. Psychiatry, 164, No. 9, 1379-1384 (2007).
8. C. Otte, S. Wüst, S. Zhao, et al., Psychoneuroendocrinology, 34, No. 10, 1574-1581 (2009).
9. B. Phillips-Bute, J. P. Mathew, J. A. Blumenthal, et al., Psychosom. Med., 70, No. 9, 953-959 (2008).